- Home
- ROIV vs WPP Comparison
ROIV vs WPP Comparison
Compare ROIV & WPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | WPP |
|---|---|---|
| Founded | 2014 | 1985 |
| Country | United Kingdom | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 5.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ROIV | WPP |
|---|---|---|
| Price | $21.78 | $22.90 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 8 | 1 |
| Target Price | ★ $24.31 | N/A |
| AVG Volume (30 Days) | ★ 8.4M | 522.0K |
| Earning Date | 02-09-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 9.32% |
| EPS Growth | N/A | ★ 86.47 |
| EPS | N/A | ★ 0.47 |
| Revenue | $20,329,000.00 | ★ $19,423,208,660.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $741.42 | N/A |
| P/E Ratio | ★ N/A | $47.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $17.47 |
| 52 Week High | $23.47 | $49.12 |
Technical Indicators
Market Signals| Indicator | ROIV | WPP |
|---|---|---|
| Relative Strength Index (RSI) | 53.52 | 58.53 |
| Support Level | $21.15 | $22.32 |
| Resistance Level | $22.14 | $23.92 |
| Average True Range (ATR) | 0.65 | 0.57 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 52.76 | 47.26 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About WPP WPP plc
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.